CONTROLLED TRIAL OF PULSE VS CONTINUOUS CYCLOPHOSPHAMIDE (CY) AND PREDNISOLONE (P) IN THE TREATMENT OF SYSTEMIC VASCULITIS

CONTROLLED TRIAL OF PULSE VS CONTINUOUS CYCLOPHOSPHAMIDE (CY) AND PREDNISOLONE (P) IN THE TREATMENT OF SYSTEMIC VASCULITIS

Bibliographic Details
Main Authors:	Luqmani, R, Pall, A, Adu, D, Moots, R, Richards, N, Howie, A, Michael, J, Emery, P, Bacon, P
Format:	Journal article
Published:	1993

Similar Items

Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis.
by: Adu, D, et al.
Published: (1997)

Cyclophosphamide and systemic vasculitis.
by: Luqmani, R, et al.
Published: (1993)

Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.
by: Luqmani, R, et al.
Published: (1994)

Relapses in patients with a systemic vasculitis.
by: Gordon, M, et al.
Published: (1993)

VITAL (Vasculitis Integrated Assessment Log) assessment of vasculitis.
by: Bacon, P, et al.
Published: (1995)

Optimisation of cyclophosphamide therapy in systemic vasculitis.
by: Richmond, R, et al.
Published: (1998)

FUNCTIONAL ASSESSMENT IN VASCULITIS USING THE SF-36
by: Exley, A, et al.
Published: (1995)

Pulse vs daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: a randomized controlled trial
by: Harper, L, et al.
Published: (2009)

Necrotizing vasculitis--relapse despite cytotoxic therapy.
by: Gordon, M, et al.
Published: (1993)

Examination of disease severity in systemic vasculitis from the novel perspective of damage using the vasculitis damage index (VDI).
by: Exley, A, et al.
Published: (1998)

THE VASCULITIS DAMAGE INDEX (VDI)
by: Exley, A, et al.
Published: (1995)

Randomized trial of rituximab vs cyclophosphamide for ANCA-associated renal vasculitis: RITUXVAS
by: Jones, R, et al.
Published: (2009)

Outcome in systemic vasculitis.
by: Luqmani, R, et al.
Published: (1998)

Functional outcome vs damage in systemic vasculitis
by: Exley, A, et al.
Published: (1996)

Vasculitis integrated total assessment log (VITAL): A system for clinical evaluation of vasculitis.
by: Luqmani, R, et al.
Published: (1996)

Azathioprine, cyclophosphamide and chlorambucil.
by: Luqmani, R, et al.
Published: (1990)

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.
by: Jones, R, et al.
Published: (2010)

Randomized trial of cyclophosphamide versus methotrexate for induction of remission in "non-renal" AbCA-associated vasculitis.
by: de Groot, K, et al.
Published: (2003)

Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up.
by: Harper, L, et al.
Published: (2012)

Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
by: De Groot, K, et al.
Published: (2005)

Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.
by: de Groot, K, et al.
Published: (2009)

Treatment of vasculitis in rheumatoid arthritis.
by: Luqmani, R, et al.
Published: (1994)

A multi-centre randomised trial of cyclophosphamide versus azathioprine during remission in ANCA-associated systemic vasculitis (Cycazarem).
by: Luqmani, R, et al.
Published: (1999)

Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides.
by: Exley, A, et al.
Published: (1997)

Pulse versus daily oral CyP for induction of remission in ANCA-associated vasculitis. A European, multi-centre randomized controlled trial: long-term follow-up
by: Harper, L, et al.
Published: (2011)

Correlation of blood levels of soluble vascular cell adhesion molecule-1 with disease activity in systemic lupus erythematosus and vasculitis.
by: Janssen, B, et al.
Published: (1994)

Vasculitis: an update.
by: Luqmani, R
Published: (2014)

Vasculitis: an update.
by: Luqmani, R
Published: (2014)

MUKtwelve protocol: a phase II randomised, controlled, open, parallel group, multicentre trial of selinexor, cyclophosphamide and prednisolone (SCP) versus cyclophosphamide and prednisolone (CP) in patients with relapsed or refractory multiple myeloma
by: Andrew Hall, et al.
Published: (2022-10-01)

ANCA POSITIVE AND ANCA NEGATIVE MICROSCOPIC POLYARTERITIS
by: Adu, D, et al.
Published: (1994)

Classical versus non-renal Wegener's granulomatosis.
by: Luqmani, R, et al.
Published: (1994)

Birmingham Vasculitis Activity Score (BVAS) for use in European multi-centre clinical trials
by: Luqmani, R, et al.
Published: (2001)

Evaluation of histological changes induced by prednisolone and cyclophosphamide in some organs of male albino mice
by: Sahar A AL-Sharqi, et al.
Published: (2022-06-01)

Validation of the Birmingham Vasculitis Activity Score (BVAS) for use in European multi-centre clinical trials.
by: Luqmani, R, et al.
Published: (2000)

Discontinuation of therapies in vasculitis.
by: Luqmani, R
Published: (2013)

CLASSIFICATION AND DIAGNOSIS OF VASCULITIS
by: Luqmani, R
Published: (2012)

Discontinuation of therapies in vasculitis.
by: Luqmani, R
Published: (2013)

Discontinuation of therapies in vasculitis.
by: Luqmani, R
Published: (2013)

Pharmacotherapy of vasculitis.
by: Chan, M, et al.
Published: (2009)

Metronomic Chemotherapy Based on Topotecan or Topotecan and Cyclophosphamide Combination (CyTo) in Advanced, Pretreated Ovarian Cancer
by: Piotr J. Wysocki, et al.
Published: (2023-02-01)